| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |